Table 4 Adverse events
|  | CD34-selected (n = 11) | Unmanipulated (n = 8) | p value |
|---|---|---|---|
Grade 3 or 4 adverse event | 6 (55) | 2 (25) | 0.35 |
Viral infections | 9 (82) | 2 (25) | 0.02 |
CMV infection | 7 (64) | 1 (13) | 0.06 |
Herpes zoster | 6 (55) | 0 (0) | 0.02 |
Adenovirus haemorrhagic cystitis | 2 (18) | 0 (0) | 0.49 |
Bacterial pneumonia | 1 (9) | 0 (0) | 1.00 |
Sepsis | 2 (18) | 1 (13) | 1.00 |
Cardiovascular | 4 (36) | 2 (25) | 1.00 |
Pulmonary | 1 (9) | 1 (13) | 1.00 |
Gastrointestinal haemorrhage | 2 (18) | 0 (0) | 0.49 |
Hepatic | 6 (55) | 4 (50) | 1.00 |